Efrat Dotan

8.8k citations
142 papers · 3.1k · 1 hit paper · h-index 25

Impact in

Papers in

    • Pancreatic and Hepatic Oncology Research 34
    • Colorectal Cancer Treatments and Studies 21
    • Cancer Treatment and Pharmacology 11
    • HER2/EGFR in Cancer Research 10
    • Peptidase Inhibition and Analysis 10
    • Frailty in Older Adults 22

Efrat Dotan

127 papers receiving 3.0k citations

Efrat Dotan's Hit Papers

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study 2020 · 1.0k citations
1.0k0+2+4Years since publication2505007501000

Peers

Efrat Dotan
Comparison fields: 5 of 101
  • Geriatrics and Gerontology 172
  • Oncology 1.3k
  • Cancer Research 371
  • Surgery 1.1k
  • Pathology and Forensic Medicine 280
Replace Mehmet Asım Bilen with:
Mehmet Asım Bilen United States
Luigi Manzione Italy
Anne Floquet France
Carmen Guillén‐Ponce Spain
Thomas A. Abrams United States
H. Curé France
Annamaria Ferrero Italy
Ben L. Sanford United States
B. Massidda Italy
Ángela Lamarca United Kingdom
Efrat Dotan relative to Mehmet Asım Bilen United States Mehmet Asım Bilen's profile →
Citations per field
00.5×3.0×
Mehmet Asım Bilen · 1×
Citations per year

Countries citing papers authored by Efrat Dotan

Since Specialization
Citations

This map shows the geographic impact of Efrat Dotan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Dotan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Dotan more than expected).

Fields of papers citing papers by Efrat Dotan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efrat Dotan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Dotan. The network helps show where Efrat Dotan may publish in the future.

Co-authors

The 25 scholars most cited alongside Efrat Dotan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Efrat Dotan Line = papers co-authored together Efrat Dotan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Hit paper breakdown →
20201021
2 2014206
3
Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin's Lymphoma.
2010123
4 202089
5 202186
6 201786
7 201984
8 201184
9 200963
10 202062
11 202255
12 202248
13 201648
14 201247
15 201846
16 201645
17 201444
18 201943
19 201542
20 201235

About Efrat Dotan

Efrat Dotan is a scholar working on Oncology, Geriatrics and Gerontology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 142 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (34 papers), Frailty in Older Adults (22 papers), Colorectal Cancer Treatments and Studies (21 papers), Cancer Genomics and Diagnostics (13 papers), Cancer Treatment and Pharmacology (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), HER2/EGFR in Cancer Research (10 papers) and Peptidase Inhibition and Analysis (10 papers). The work is most often cited by research in Geriatrics and Gerontology (172 citations), Oncology (1.3k citations), Cancer Research (371 citations), Surgery (1.1k citations) and Pathology and Forensic Medicine (280 citations). Efrat Dotan has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Steven J. Cohen, Antoine Hollebecque, Do‐Youn Oh, Gina M. Vaccaro, Mitesh J. Borad, Daniel V.T. Catenacci, Adrian Murphy, Vaibhav Sahai, Christine Lihou and Hui‐Ling Zhen. Their work appears in journals such as Journal of Clinical Oncology, Journal of Geriatric Oncology, Cancer Research, Annals of Oncology and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact